Boston, MA -- (SBWIRE) -- 03/26/2013 -- Introduction

In 1996 Ciba-Geigy merged with Sandoz to form Novartis. In 1997, 2000, 2006, and 2007 it divested its specialty chemicals, agribusiness, nutrition, and medical nutrition and baby foods businesses, respectively. Novartis has also made acquisitions to strengthen its position in the healthcare market, and now generates 100% of revenues from healthcare, and operates through five diverse segments.

Features and benefits

- MarketLine Case Studies describe topics such as innovative products, business models, and significant company acquisitions.
- Fact-based and presented in an accessible style, they explain the rationale of commercial decisions and illustrate wider market and economic trends.

View Full Report Details and Table of Contents

Highlights

The global population is growing older, and Novartis Pharmaceuticals provides products aimed at high- and middle-income countries, where a higher proportion of the population reaches old age. Novartis Pharmaceuticals' product lines reflect the most common causes of death in these countries.
While vaccines are estimated to save the lives of over 3 million people annually, the World Health Organization (WHO) estimates that over 3 million people die annually due to a lack of access to vaccines. The Vaccines and Diagnostics division has a product development portfolio of 15 potential products in various stages of clinical development.
The Consumer Health segment represents only 8% of sales. Despite this, the segment is important in providing stable growth to offset fluctuations in the less stable segments of Sandoz and Pharmaceuticals.

Your key questions answered

- How has Novartis changed to generate 100% of its revenues from healthcare sales, rather than the 45% that healthcare sales contributed in 1996?
- What mergers, acquisitions, and divestments has Novartis made, and how have these affected the company?
- Which areas of healthcare is Novartis present in?

About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- Novartis AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
- Sonic Healthcare Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
- GE Healthcare - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
- Tenet Healthcare Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
- Kindred Healthcare, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
- Siemens Healthcare - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
- Novartis AG (NVAX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- NasVax Ltd. (NSVX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- Siemens Healthcare Diagnostics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
- Bayer HealthCare Pharmaceuticals - Pharmaceuticals & Healthcare - Deals and Alliances Profile